Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7170485
[patent_doc_number] => 20040077847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products'
[patent_app_type] => new
[patent_app_number] => 10/299636
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 59870
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077847.pdf
[firstpage_image] =>[orig_patent_app_number] => 10299636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/299636 | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6761933
[patent_doc_number] => 20030125295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Novel nucleic acid and amino acid sequences'
[patent_app_type] => new
[patent_app_number] => 10/298794
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12799
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10298794
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/298794 | Novel nucleic acid and amino acid sequences | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6739687
[patent_doc_number] => 20030157056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Modified cytokines for use in cancer therapy'
[patent_app_type] => new
[patent_app_number] => 10/287811
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13131
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287811
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287811 | Modified cytokines for use in cancer therapy | Nov 4, 2002 | Issued |
Array
(
[id] => 7225232
[patent_doc_number] => 20050255084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/493553
[patent_app_country] => US
[patent_app_date] => 2002-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13069
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255084.pdf
[firstpage_image] =>[orig_patent_app_number] => 10493553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/493553 | Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy | Oct 23, 2002 | Abandoned |
Array
(
[id] => 7269807
[patent_doc_number] => 20040058325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Gene expression in biological conditions'
[patent_app_type] => new
[patent_app_number] => 10/169113
[patent_app_country] => US
[patent_app_date] => 2002-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40093
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 43
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058325.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169113
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169113 | Gene expression in biological conditions | Oct 22, 2002 | Abandoned |
Array
(
[id] => 7199239
[patent_doc_number] => 20040086485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Chemeric viral vectors for gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/264839
[patent_app_country] => US
[patent_app_date] => 2002-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24133
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10264839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/264839 | Chemeric viral vectors for gene therapy | Oct 3, 2002 | Abandoned |
Array
(
[id] => 376977
[patent_doc_number] => 07312077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'Insulin-secreting immortalized liver cell line modified by glucose sensitivity'
[patent_app_type] => utility
[patent_app_number] => 10/432592
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5214
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/312/07312077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432592 | Insulin-secreting immortalized liver cell line modified by glucose sensitivity | Oct 1, 2002 | Issued |
Array
(
[id] => 6765593
[patent_doc_number] => 20030099992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Genes associated with mast cell activation'
[patent_app_type] => new
[patent_app_number] => 10/260715
[patent_app_country] => US
[patent_app_date] => 2002-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14994
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099992.pdf
[firstpage_image] =>[orig_patent_app_number] => 10260715
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/260715 | Genes associated with mast cell activation | Sep 30, 2002 | Abandoned |
Array
(
[id] => 7074701
[patent_doc_number] => 20050147969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Genes associated with mast cell activation'
[patent_app_type] => utility
[patent_app_number] => 10/491188
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14857
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491188
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491188 | Genes associated with mast cell activation | Sep 26, 2002 | Abandoned |
Array
(
[id] => 6715440
[patent_doc_number] => 20030026788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Use of extracellular matrix tissue to preserve cultured cell phenotype'
[patent_app_type] => new
[patent_app_number] => 10/253211
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1208
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026788.pdf
[firstpage_image] =>[orig_patent_app_number] => 10253211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/253211 | Use of extracellular matrix tissue to preserve cultured cell phenotype | Sep 23, 2002 | Abandoned |
Array
(
[id] => 6659979
[patent_doc_number] => 20030079239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Gene Associated with bone disorders'
[patent_app_type] => new
[patent_app_number] => 10/252958
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15963
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20030079239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252958
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252958 | Gene Associated with bone disorders | Sep 23, 2002 | Abandoned |
Array
(
[id] => 6720303
[patent_doc_number] => 20030053991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders'
[patent_app_type] => new
[patent_app_number] => 10/239804
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23518
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20030053991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239804
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239804 | Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders | Sep 22, 2002 | Abandoned |
Array
(
[id] => 6814111
[patent_doc_number] => 20030073661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Method of modulating or examining Ku70 levels in cells'
[patent_app_type] => new
[patent_app_number] => 10/247045
[patent_app_country] => US
[patent_app_date] => 2002-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15995
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247045
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247045 | Method of modulating or examining Ku70 levels in cells | Sep 18, 2002 | Abandoned |
Array
(
[id] => 6796369
[patent_doc_number] => 20030175242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Cell therapy system'
[patent_app_type] => new
[patent_app_number] => 10/246293
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22347
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175242.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246293
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246293 | Cell therapy system | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6668866
[patent_doc_number] => 20030113850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/244947
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45002
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10244947
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/244947 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 16, 2002 | Abandoned |
Array
(
[id] => 902114
[patent_doc_number] => 07335353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Porcine cells comprising an adenovirus E3 gene region'
[patent_app_type] => utility
[patent_app_number] => 10/245603
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 14851
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335353.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245603 | Porcine cells comprising an adenovirus E3 gene region | Sep 15, 2002 | Issued |
Array
(
[id] => 935322
[patent_doc_number] => 06974671
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-13
[patent_title] => 'Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoter'
[patent_app_type] => utility
[patent_app_number] => 10/244045
[patent_app_country] => US
[patent_app_date] => 2002-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 13
[patent_no_of_words] => 9938
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/974/06974671.pdf
[firstpage_image] =>[orig_patent_app_number] => 10244045
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/244045 | Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoter | Sep 10, 2002 | Issued |
Array
(
[id] => 6682703
[patent_doc_number] => 20030118567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Cell-based therapy for the pulmonary system'
[patent_app_type] => new
[patent_app_number] => 10/236980
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16689
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10236980
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/236980 | Cell-based therapy for the pulmonary system | Sep 8, 2002 | Abandoned |
Array
(
[id] => 7097685
[patent_doc_number] => 20050130144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs'
[patent_app_type] => utility
[patent_app_number] => 10/490302
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8306
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490302 | Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs | Aug 29, 2002 | Abandoned |
Array
(
[id] => 397536
[patent_doc_number] => 07294505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Stable episomal vectors'
[patent_app_type] => utility
[patent_app_number] => 10/231467
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2464
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231467
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231467 | Stable episomal vectors | Aug 29, 2002 | Issued |